Crossmark

A genomic signature for accurate classification and prediction of clinical outcomes in cancer patients treated with immune checkpoint blockade immunotherapy

Crossref DOI link: https://doi.org/10.1038/s41598-020-77653-3

Published Online: 2020-11-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lu, Mei

Wu, Kuan-Han Hank

Trudeau, Sheri

Jiang, Margaret

Zhao, Joe

Fan, Elliott
License Information

Text and Data Mining valid from 2020-11-25

Version of Record valid from 2020-11-25
More Information

Article History

Received: 23 June 2020

Accepted: 15 November 2020

First Online: 25 November 2020

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below